BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 17118729)

  • 1. Thiazopyr and thyroid disruption: case study within the context of the 2006 IPCS Human Relevance Framework for analysis of a cancer mode of action.
    Dellarco VL; McGregor D; Berry SC; Cohen SM; Boobis AR
    Crit Rev Toxicol; 2006; 36(10):793-801. PubMed ID: 17118729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of thiazopyr-induced effects on thyroid hormone homeostasis in male Sprague-Dawley rats.
    Hotz KJ; Wilson AG; Thake DC; Roloff MV; Capen CC; Kronenberg JM; Brewster DW
    Toxicol Appl Pharmacol; 1997 Jan; 142(1):133-42. PubMed ID: 9007042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mode-of-action analysis for induction of rat liver tumors by pyrethrins: relevance to human cancer risk.
    Osimitz TG; Lake BG
    Crit Rev Toxicol; 2009; 39(6):501-11. PubMed ID: 19463055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case study: weight of evidence evaluation of the human health relevance of thiamethoxam-related mouse liver tumors.
    Pastoor T; Rose P; Lloyd S; Peffer R; Green T
    Toxicol Sci; 2005 Jul; 86(1):56-60. PubMed ID: 15716475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IPCS framework for analyzing the relevance of a cancer mode of action for humans.
    Boobis AR; Cohen SM; Dellarco V; McGregor D; Meek ME; Vickers C; Willcocks D; Farland W
    Crit Rev Toxicol; 2006; 36(10):781-92. PubMed ID: 17118728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mode of action in relevance of rodent liver tumors to human cancer risk.
    Holsapple MP; Pitot HC; Cohen SM; Boobis AR; Klaunig JE; Pastoor T; Dellarco VL; Dragan YP
    Toxicol Sci; 2006 Jan; 89(1):51-6. PubMed ID: 16221960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mode-of-action framework for evaluating the relevance of rodent forestomach tumors in cancer risk assessment.
    Proctor DM; Gatto NM; Hong SJ; Allamneni KP
    Toxicol Sci; 2007 Aug; 98(2):313-26. PubMed ID: 17426108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 4-Aminobiphenyl and DNA reactivity: case study within the context of the 2006 IPCS Human Relevance Framework for Analysis of a cancer mode of action for humans.
    Cohen SM; Boobis AR; Meek ME; Preston RJ; McGregor DB
    Crit Rev Toxicol; 2006; 36(10):803-19. PubMed ID: 17118730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formaldehyde and glutaraldehyde and nasal cytotoxicity: case study within the context of the 2006 IPCS Human Framework for the Analysis of a cancer mode of action for humans.
    McGregor D; Bolt H; Cogliano V; Richter-Reichhelm HB
    Crit Rev Toxicol; 2006; 36(10):821-35. PubMed ID: 17118731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of the carcinogenic activity of diethanolamine and evidence of choline deficiency as a plausible mode of action.
    Leung HW; Kamendulis LM; Stott WT
    Regul Toxicol Pharmacol; 2005 Dec; 43(3):260-71. PubMed ID: 16188361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mode of action for induction of thyroid gland tumors by Pyrethrins in the rat.
    Finch JM; Osimitz TG; Gabriel KL; Martin T; Henderson WJ; Capen CC; Butler WH; Lake BG
    Toxicol Appl Pharmacol; 2006 Aug; 214(3):253-62. PubMed ID: 16626768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acrylamide carcinogenicity.
    Klaunig JE
    J Agric Food Chem; 2008 Aug; 56(15):5984-8. PubMed ID: 18624430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IPCS conceptual framework for evaluating a mode of action for chemical carcinogenesis.
    Sonich-Mullin C; Fielder R; Wiltse J; Baetcke K; Dempsey J; Fenner-Crisp P; Grant D; Hartley M; Knaap A; Kroese D; Mangelsdorf I; Meek E; Rice JM; Younes M;
    Regul Toxicol Pharmacol; 2001 Oct; 34(2):146-52. PubMed ID: 11603957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mode of carcinogenic action of pesticides inducing thyroid follicular cell tumors in rodents.
    Hurley PM
    Environ Health Perspect; 1998 Aug; 106(8):437-45. PubMed ID: 9681970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinogenic mode of action of folpet in mice and evaluation of its relevance to humans.
    Cohen SM; Gordon EB; Singh P; Arce GT; Nyska A
    Crit Rev Toxicol; 2010 Jul; 40(6):531-45. PubMed ID: 20521864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro perturbations of targets in cancer hallmark processes predict rodent chemical carcinogenesis.
    Kleinstreuer NC; Dix DJ; Houck KA; Kavlock RJ; Knudsen TB; Martin MT; Paul KB; Reif DM; Crofton KM; Hamilton K; Hunter R; Shah I; Judson RS
    Toxicol Sci; 2013 Jan; 131(1):40-55. PubMed ID: 23024176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence-based dose-response assessment for thyroid tumorigenesis from acrylamide.
    Dourson M; Hertzberg R; Allen B; Haber L; Parker A; Kroner O; Maier A; Kohrman M
    Regul Toxicol Pharmacol; 2008 Dec; 52(3):264-89. PubMed ID: 18775759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A classification framework and practical guidance for establishing a mode of action for chemical carcinogens.
    Butterworth BE
    Regul Toxicol Pharmacol; 2006 Jun; 45(1):9-23. PubMed ID: 16530901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mode of action and human relevance of pronamide-induced rat thyroid tumors.
    Papineni S; Marty MS; Rasoulpour RJ; LeBaron MJ; Pottenger LH; Eisenbrandt DL
    Regul Toxicol Pharmacol; 2015 Apr; 71(3):541-51. PubMed ID: 25707858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitrapyrin: a scientific advisory group review of the mode of action and carcinogenicity in B6C3F1 mice.
    Yano BL; Hardisty JF; Seely JC; Butterworth BE; McConnell EE; Swenberg JA; Williams GM; Stebbins KE; Golllapudi BB; Eisenbrandt DL
    Regul Toxicol Pharmacol; 2008 Jun; 51(1):53-65. PubMed ID: 18367300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.